JRCT ID: jRCT1030210581
Registered date:25/01/2022
Evaluation of the effect of nutritional therapy intervention in outpatients undergoing chemotherapy
Basic Information
Recruitment status | Suspended |
---|---|
Health condition(s) or Problem(s) studied | Digestive organ malignant tumor |
Date of first enrollment | 25/01/2022 |
Target sample size | 600 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | For outpatient chemotherapy patients, we provide a nutrition education and a nutrition care (1-2 times/month). Correlations, and the like with the change of the nutrition index (caloric intake, nutrient sufficiency rate, diet balance, and the like), a blood biochemistry test value (Alb, prealbumin, T-cho, TG, ChE, and the like) and the anthropometry (weight, somatic fat volume, skeletal muscle mass, and the like) evaluate) and test the effect of the aggressive nutrition care by the comparison with the non-interposer. Also, by an evaluation whether improvement (presence or absence of reduction of stress and the anxiety in the dietary management, presence or absence, and the like of consciousness change for the eating habits management) of the meal quality of life was obtained by a nutrition education, we determine an effect of the intervention. |
Outcome(s)
Primary Outcome | Nutritional status evaluation (biochemical examination of blood, frail evaluation, G8 evaluation or CAG evaluation, PG-SGA, anthropometry (weight, skinfold thickness) such as muscle mass, and the like, nutritional requirements, quantity of intake nutrient (sufficiency rate) to include, will, opinion to a nutrition care |
---|---|
Secondary Outcome | Clinical history, treatment strategy (we include the intention, and the like for the treatment), living condition, background (family constitution, living environment, the money situation, taste, activity, and so on), |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1.Outpatient chemotherapy patients (regimen subjects becoming a continuous administration or the administration week for two weeks) 2.Patients as described in 1 corresponding to the undernutrition risk extraction criteria that we set at this hospital |
Exclude criteria | 1.Patients (including the change to chemotherapy in the internal use) who came to have difficulty with outpatient chemotherapy continuation 2.Patients with social, religious, or psychological problems that make interventions other than the primary treatment difficult 3.The patients with the defect for data |
Related Information
Primary Sponsor | Sato Hiroshi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Hiromi Mori |
Address | 1397-1, Yamane, Hidaka-shi, Saitama Saitama Japan 350-1298 |
Telephone | +81-49-284-4218 |
hm0249@5931.saitama-med.ac.jp | |
Affiliation | Saitama Medical University International Medical Center |
Scientific contact | |
Name | Hiroshi Sato |
Address | 1397-1, Yamane, Hidaka-shi, Saitama Saitama Japan 350-1298 |
Telephone | +81-49-284-4218 |
hs8401@5931.saitama-med.ac.jp | |
Affiliation | Saitama Medical University International Medical Center |